DrugPatentWatch Database Preview
Litigation Details for Bayer Healthcare AG v. Teva Pharmaceuticals U.S.A., Inc. (D. Del. 2007)
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Bayer Healthcare AG v. Teva Pharmaceuticals U.S.A., Inc. (D. Del. 2007)
Docket | Start Trial | Date Filed | 2007-04-05 |
Court | District Court, D. Delaware | Date Terminated | 2008-05-19 |
Cause | 35:271 Patent Infringement | Assigned To | Sue Lewis Robinson |
Jury Demand | None | Referred To | |
Parties | BAYER HEALTHCARE AG; BAYER PHARMACEUTICALS CORPORATION; TEVA PHARMACEUTICALS U.S.A., INC. | ||
Patents | 4,990,517; 5,607,942 | ||
Attorneys | Anne Shea Gaza; Ashley Blake Stitzer; Frederick L. Cottrell , III; Richard D. Kirk | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Bayer Healthcare AG v. Teva Pharmaceuticals U.S.A., Inc.
Details for Bayer Healthcare AG v. Teva Pharmaceuticals U.S.A., Inc. (D. Del. 2007)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2007-04-05 | 1 | Complaint | forth iierein. 7. United States Patent No. 4,990,517 (“the ’517 patent”), entitled “7-(1~ Pyrrolidinyl…expiration dates of United States Patent l\io,. 4,990,517 and United States Patent No. 5,607,942; (b) A preliminary… United States Patent nn Petersen et al. Filed 04/05/2007 t Page 2 Of 60 4,990,517 sea s, 1991 [tt… sTA'rES PATENT AND mDEMARK orr-acs CERTIFICATE OF CORRECTION PATENTNO. 2 4,990,517 DATED : February…TRADEMARK nance CERTIFICATE OF CORRECTION PATENT NO` :4,990,517 P;tgc 'l ol" 2 DATED ; Febrcary | External link to document |
2007-04-05 | 4 | Patent/Trademark Report to Commissioner | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 4,990,517; 5,607,942; (els) (… OF PATENT OR TRADEMARK TRADEMARK NO. OR TRADEMARK 1 4,990,517 …Pharmaceuticals Corporation PATENT OR DATE OF PATENT … G Other Pleading PATENT OR DATE OF PATENT …REPORT ON THE TO: Director of the U.S. Patent and Trademark Office FILING | External link to document |
2007-04-24 | 7 | Answer to Complaint | States Patent No. 4,990,517 (“the ‘5 17 patent”) issued on February 5, 1991 and that the ‘517 patent bears…drug product before the expiration of U.S. Patents 4,990,517 and 5,607,942. Teva USA denies the remaining…States Patent No. 5,607,942 (“the ‘942 patent”) issued on March 4, 1997 and that the ‘942 patent bears …USA admits this is an action for patent inningement under the patent laws of the United States, Title …Healthcare AG (“BHC”) owns both the ‘5 17 patent and the ‘942 patent, and Teva USA denies the remaining allegations | External link to document |
2007-04-27 | 8 | Motion to Consolidate Cases | U,S, patents owned by BHC, U.S‘ l~"atent Nosr 4,990,5}7 (“the ’Sli’ patent“) and 5,607,942 (“the…234-SLR and Case No,. O`Y~IQS»SLR are actions for patent infringement under the I"iatch»Waxman Act;…the ’942 patent”), based on Teva’s filing of Abbreviated Nevv Drug Applications seeking to sell drug products… claims that the pertinent claims of these two patents are invalid and/or not infringed; 4, There Wiii… 2007 19 May 2008 1:07-cv-00195 830 Patent None District Court, D. Delaware | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |